Rose Tenorio*
Acute traumatic musculoskeletal pain is a common occurrence in athletes, often leading to significant functional impairment and delayed return to sports activities. Over the years, there have been substantial advancements in pharmacological treatment options aimed at managing pain and expediting recovery in athletes. This literature review aims to provide a comprehensive overview of the recent developments in pharmacotherapy for acute traumatic musculoskeletal pain in athletes. The review encompasses various classes of medications, including Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), opioids, muscle relaxants, and emerging therapies, such as regenerative medicine and neuromodulators. Additionally, the review explores the efficacy, safety, and potential limitations of these pharmacological interventions, along with their implications for optimizing athletic performance and minimizing the risk of re-injury. By shedding light on the latest advancements in pharmacotherapy, this review aims to contribute to the on-going efforts in enhancing pain management strategies and promoting successful recovery in athletes.
Comparte este artículo
English 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 